Haemophilus influenzae type b infections are preventable everywhere

Lancet

Volumn 349, Issue 9060, 1997, Pages 1186-1187

  Steinhoff, M C ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS VACCINE;

BACTERIAL MENINGITIS; DEVELOPED COUNTRY; DRUG COST; DRUG EFFICACY; GAMBIA; GRAM NEGATIVE INFECTION; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; INDUSTRIALIZATION; PNEUMONIA; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0030887827     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)22017-9     Document Type: Note

References (9)

1. JH Ward influenzae vaccines SA Plotkin EA Mortimer Jr Vaccines 2nd ed. 1994 WB Saunders Co Philadelphia 337 386
2. JB Robbins R Schneerson P Anderson DH Smith Prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b. Impact on public health and implications for other polysaccharide-based vaccines JAMA 276 1996 1181 1185
3. GT Keusch Should Haemophilus influenzae type b conjugate vaccine be introduced into EPI? Lancet 339 1992 802 803
4. MC Steinhoff Developing and deploying pneumococcal and haemophilus vaccines Lancet 342 1993 630 631
5. R Lagos I Horwitz J Toro Large scale, postlicensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: practicality and effectiveness in preventing invasive Haemophilus influenzae type b infections Pediatr Infect Dis J 15 1996 216 222
6. A Funkhouser MC Steinhoff J Ward H influenzae disease and immunization in developing countries Rev Infect Dis 13 1991 S542 S554
7. Proceedings of International Seminar on Hib in Asia meeting, WHO, AMP. Indonesia, Dec 1996.
8. Bellagio conference. Global availability of new vaccines. Rockefeller Foundation, Feb 1997.
9. PF Wright Approaches to prevention of acute bacterial meningitis in developing countries Bull World Health Organ 67 1989 479 486